Tryptophan depletion affects the autonomic stress response in generalized social anxiety disorder

Psychoneuroendocrinology

Volumn 34, Issue 10, 2009, Pages 1590-1594

  van Veen, J Frederieke ^a   van Vliet, Irene M ^a   de Rijk, Roel H ^b   van Pelt, Johannes ^a   Mertens, Bart ^a   Fekkes, Durk ^c   Zitman, Frans G ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

alpha Amylase; Autonomic nervous system; Hydrocortisone; Hypothalamic pituitary adrenal axis; Phobic disorders; Serotonin

Indexed keywords

AMYLASE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CITALOPRAM; HYDROCORTISONE; PLACEBO; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRYPTOPHAN;

ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENERALIZED SOCIAL ANXIETY DISORDER; GROUPS BY AGE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MENTAL STRESS; PRIORITY JOURNAL; PUBLIC SPEAKING; RANDOMIZED CONTROLLED TRIAL; SEROTONINERGIC TRANSMISSION; SEX DIFFERENCE; SOCIAL PHOBIA; TASK PERFORMANCE;

ANXIETY DISORDERS; AUTONOMIC NERVOUS SYSTEM; CITALOPRAM; FEMALE; HUMANS; HYDROCORTISONE; MALE; SALIVA; SALIVARY ALPHA-AMYLASES; SPEECH; STRESS, PSYCHOLOGICAL; TRYPTOPHAN;

EID: 70349792670     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2009.05.007     Document Type: Article

References (15)

1. Argyropoulos S.V., Hood S.D., Adrover M., Bell C.J., Rich A.S., Nash J.R., Rich N.C., Witchel H.J., and Nutt D.J. Tryptophan depletion reverses the therapeutic effect of selective serotonin reuptake inhibitors in social anxiety disorder. Biol. Psychiatry 56 (2004) 503-509
2. Beck A.T., and Steer R.A. Manual for the Revised Beck Depression Inventory (1987), Psychological Corporation, San Antonio, TX
3. Blanco C., Schneier F.R., Schmidt A., Blanco-Jerez C.R., Marshall R.D., Sanchez-Lacay A., and Liebowitz M.R. Pharmacological treatment of social anxiety disorder: a meta-analysis. Depress. Anxiety 18 (2003) 29-40
4. Condren R.M., O'Neill A., Ryan M.C., Barrett P., and Thakore J.H. HPA axis response to a psychological stressor in generalised social phobia. Psychoneuroendocrinology 27 (2002) 693-703
5. Fekkes D., van Dalen A., Edelman M., and Voskuilen A. Validation of the determination of amino acids in plasma by high-performance liquid chromatography using automated pre-column derivatization with o-phthaldialdehyde. J. Chromatogr. B: Biomed. Appl. 669 (1995) 177-186
6. Gerlach A.L., Wilhelm F.H., and Roth W.T. Embarrassment and social phobia: the role of parasympathetic activation. J. Anxiety Disord. 17 (2003) 197-210
7. Gijsman H.J., van Gerven J.M., de Kam M.L., Schoemaker R.C., Pieters M.S., Weemaes M., de Rijk R., van der P.J., and Cohen A.F. Placebo-controlled comparison of three dose-regimens of 5-hydroxytryptophan challenge test in healthy volunteers. J. Clin. Psychopharmacol. 22 (2002) 183-189
8. Hood S.D., Bell C.J., and Nutt D.J. Acute tryptophan depletion. Part I. Rationale and methodology. Aust. N. Z. J. Psychiatry 39 (2005) 558-564
9. Kirschbaum C., Pirke K.M., and Hellhammer D.H. The 'Trier social stress test'-a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology (1993) 28
10. Nater U.M., Rohleder N., Schlotz W., Ehlert U., and Kirschbaum C. Determinants of the diurnal course of salivary alpha-amylase. Psychoneuroendocrinology 32 (2007) 392-401
11. Tassin J.P. Uncoupling between noradrenergic and serotonergic neurons as a molecular basis of stable changes in behaviour induced by repeated drugs of abuse. Biochem. Pharmacol. 75 (2008) 85-97
12. 123I-β-(4-iodophenyl)-tropane SPECT. J. Nucl. Med. 49 (2008) 757-763
13. Van Veen J.F., Van der Wee N.J., Fiselier J., Van Vliet I.M., and Westenberg H.G. Behavioural effects of rapid intravenous administration of meta-chlorophenylpiperazine (m-CPP) in patients with generalized social anxiety disorder, panic disorder and healthy controls. Eur. Neuropsychopharmacol. 17 (2007) 637-642
14. Van Veen J.F., Van Vliet I.M., DeRijk R.H., Van Pelt J., Mertens B., and Zitman F.G. Elevated alpha-amylase but not cortisol in generalized social anxiety disorder. Psychoneuroendocrinology 33 (2008) 1313-1321
15. Wald F.D.M., and Mellenbergh G.J. De verkorte versie van de Nederlandse vertaling van de profile of mood states (POMS). Neth. J. Psychol. 45 (1990) 86-90